Alvarez & Marsal: New Law Clarifies Economic Substance Doctrine

Management consulting firm Alvarez & Marsal has analyzed new U.S. legislation that codifies the previously judge-made economic substance doctrine. Signed into law on March 30, 2010, the Health Care and Education Reconciliation Act aims to clarify rules and combat tax avoidance where transactions are structured primarily for tax benefits without genuine economic purpose.

The new Internal Revenue Code Section 7701(o) establishes a two-part test for the doctrine's application. First, a transaction must meaningfully change the taxpayer's economic position. Second, the taxpayer must have a substantial purpose for entering the transaction. Both prongs must be met for tax benefits to be recognized. Financial accounting benefits will not be considered a purpose if their origin stems from a reduction in federal income tax.

The legislation also introduces significant penalty provisions. A 20 percent penalty applies to tax underpayments attributable to transactions lacking economic substance that are disclosed to the IRS. For undisclosed transactions, the penalty increases to 40 percent. There are no exceptions to these penalties, including reasonable cause.

Alvarez & Marsal points out that the new statute applies only to transactions entered into after its enactment date of March 30, 2010. Certain fundamental business transactions, such as the choice between debt and equity financing or corporate structure decisions, are not altered by the new law. The analysis emphasizes a fact-specific approach to each transaction, and tax authorities do not plan to issue blanket exemptions.